Skip to main content
Fig. 3 | Infectious Agents and Cancer

Fig. 3

From: The degradation of Rap1GAP via E6AP-mediated ubiquitin-proteasome pathway is associated with HPV16/18-infection in cervical cancer cells

Fig. 3

Rap1GAP interacts with E6AP in HPV16/18 positive cervical cancer cells. Total cell lysates from HeLa, SiHa and C33A cells were used to detect the expression of Rap1GAP and E6AP in the cells (input). Then, the lysates were subjected to immunoprecipitation with an anti-Rap1GAP antibody. The pulled-down proteins were analyzed using immunoblotting. Interaction between Rap1GAP and E6AP was detected with an anti-E6AP antibody, and the immunoprecipitation efficiency of Rap1GAP was verified with an anti-Rap1GAP antibody

Back to article page